会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明申请
    • MARKERS FOR EVALUATING ESTROGENIC ACTIVITY
    • 评估雌激素活性的标记
    • WO2002093124A2
    • 2002-11-21
    • PCT/US2002/014597
    • 2002-05-10
    • SIGNAL PHARMACEUTICALS, INC.BARBOSA, Miguel, S.BRADY, Helen, A.CHAN, Kyle, W., H.PARDINAS, Jose, R.
    • BARBOSA, Miguel, S.BRADY, Helen, A.CHAN, Kyle, W., H.PARDINAS, Jose, R.
    • G01N
    • G01N33/743G01N2500/04
    • Methods are provided for evaluating estrogenic and antiestrogenic effects of candidate therapeutic agents. Such methods are generally based on assays to detect modulation of estrogen-regulated marker expression in one or more specific cell types. Agents identified using such methods may be used, for example, in the prevention and treatment of diseases such as osteoporosis, cardiovascular disease and cancer. In addition, the gene discovery approaches discussed have identified a using gene profile for estrogen regulation in vascular endothelial cells. This gene profile will allow characterization of the effects of potential SERMs in the cardiovascular system this gene profile and the assays established with these genes will enable more extensive evaluation of tissue specific properties of SERM compounds and provide a better understanding of cardiovascular effects of SERMs.
    • 提供了评估候选治疗剂的雌激素和抗雌激素作用的方法。 这样的方法通常基于检测在一种或多种特定细胞类型中调节雌激素调节标记物表达的测定。 使用这些方法鉴定的药剂可以用于例如预防和治疗诸如骨质疏松症,心血管疾病和癌症的疾病。 此外,所讨论的基因发现方法已经确定了在血管内皮细胞中使用雌激素调节的基因概况。 该基因概况将允许表征潜在的SERMs在心血管系统中的作用,该基因谱和用这些基因建立的测定将能够更广泛地评估SERM化合物的组织特异性,并且更好地了解SERM的心血管效应。